Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 Aug 4;38(10):1806–1815. doi: 10.1007/s00259-011-1871-4

Fig. 6.

Fig. 6

In vivo PET imaging of xenografted mice treated with 18F-FP-QQM. a Decay-corrected whole-body coronal microPET images of UM-SCC1 and MDA-MB-435 tumor–bearing mice at 15, 30, 60, and 120 min after injection of 3.7 MBq (100 μCi) of 18F-FP-QQM. The tumors are indicated by arrows. b ROI analysis of tumor uptake of 18F-FP-QQM at 15, 30, 60, and 120 min in UM-SCC1 and MDA-MB-435 tumor–bearing mice (n=6/group) as derived from static microPET images. c Quantification of 18F-FP-QQM uptake in UM-SCC1 tumor, liver, kidneys and muscle with and without the presence of a blocking dose of QQM peptide (n=6/group). Uptake values are shown as mean %ID/g±SD. *P<0.05